Breast cancer-related lymphedema: A literature review for clinical practice

Abstract Lymphedema is the swelling of soft tissues as a result of the accumulation of protein-rich fluid in extracellular spaces. Secondary lymphedema is precipitated by an event causing blockage or interruption of the lymphatic vessels. Secondary lymphedema is a potential complication that may affect the quality of life of patients treated for breast cancer. Life-long risk factors of post-breast cancer lymphedema are related to the extent of axillary node involvement, type of breast surgery, and radiation therapy. These factors decrease lymphatic drainage and increase stasis of fluids in the areas of skin and subcutaneous tissues that drain to regional lymph nodes. Breast cancer-related lymphedema can involve the arm and hand, as well as the breast and trunk on the operative side. Clinical symptom assessment and circumferential measures are widely used to evaluate lymphedema. Treatment of lymphedema associated with breast cancer can include combined modality approaches, compression therapy, therapeutic exercises, and pharmacotherapy.

[1]  D. E. Gary.  Lymphedema diagnosis and management , 2007, Journal of the American Academy of Nurse Practitioners.

[2]  M. Hull,et al.  Lymphedema in women treated for breast cancer. , 2000, Seminars in oncology nursing.

[3]  J. Armer,et al.  Complexities of Adherence and Post-Cancer Lymphedema Management , 2015, Journal of personalized medicine.

[4]  L. Rebegea,et al.  The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer. , 2015, Chirurgia.

[5]  Barbara L. Smith,et al.  Prevention and management of arm lymphedema in the patient with breast cancer. , 2006, The journal of supportive oncology.

[6]  Stefan Kubik,et al.  Foldi's Textbook of Lymphology: For Physicians and Lymphedema Therapists , 2007 .

[7]  P. Raina,et al.  Diagnosis and Treatment of Secondary Lymphedema , 2010 .

[8]  Isl Isl,et al.  The diagnosis and treatment of peripheral lymphedema. , 2009, Lymphology.

[9]  J. Armer.  Research on Risk Assessment for Secondary Lymphedema following Breast Cancer Treatment , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[10]  M. Fu.  Breast Cancer Survivors' Intentions of Managing Lymphedema , 2005, Cancer nursing.

[11]  W. Rief,et al.  What do women with breast cancer expect from their treatment? Correlates of negative treatment expectations about endocrine therapy , 2016, Psycho-oncology.

[12]  J. Armer,et al.  Surveillance Recommendations in Reducing Risk of and Optimally Managing Breast Cancer-Related Lymphedema , 2014, Journal of personalized medicine.

[13]  S. Ridner.  Breast cancer lymphedema: pathophysiology and risk reduction guidelines. , 2002, Oncology nursing forum.

[14]  E. Jeffs.  Treating breast cancer-related lymphoedema at the London Haven: clinical audit results. , 2006, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[15]  E. Paskett,et al.  The Epidemiology of Arm and Hand Swelling in Premenopausal Breast Cancer Survivors , 2007, Cancer Epidemiology Biomarkers & Prevention.

[16]  J. Armer,et al.  The Problem of Post-Breast Cancer Lymphedema: Impact and Measurement Issues , 2005, Cancer investigation.

[17]  Davina Porock,et al.  Predicting Breast Cancer-Related Lymphedema Using Self-Reported Symptoms , 2003, Nursing research.

[18]  M. Radina,et al.  Post-breast cancer lymphedema: understanding women's knowledge of their condition. , 2004, Oncology nursing forum.

[19]  B. Pockaj,et al.  Breast cancer-related lymphedema. , 2005, Mayo Clinic proceedings.

[20]  S. Harris,et al.  Exercise for Women With or at Risk for Breast Cancer–Related Lymphedema , 2006, Physical Therapy.

[21]  E. Paskett,et al.  Lymphedema: Knowledge, Treatment, and Impact Among Breast Cancer Survivors , 2000, The breast journal.

[22]  W. Kwan,et al.  Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  P. Ganz,et al.  Older Breast Cancer Survivors: Factors Associated with Self‐reported Symptoms of Persistent Lymphedema Over 7 years of Follow‐up , 2010, The breast journal.

[24]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[25]  J. Cormier,et al.  Minimal limb volume change has a significant impact on breast cancer survivors. , 2009, Lymphology.

[26]  M. Levine,et al.  Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[27]  M. Sieggreen,et al.  Current concepts in lymphedema management. , 2004, Advances in skin & wound care.

[28]  A. Haimovitz-Friedman,et al.  Radiation therapy causes loss of dermal lymphatic vessels and interferes with lymphatic function by TGF-beta1-mediated tissue fibrosis. , 2010, American journal of physiology. Cell physiology.

[29]  J. Armer,et al.  Post-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months. , 2010, Lymphology.

[30]  J. Shim,et al.  The diagnosis and treatment of lymphedema , 2013 .

[31]  C. Ekdahl,et al.  Breast cancer patients' experiences of lymphoedema. , 2003, Scandinavian journal of caring sciences.

[32]  M. Fu.  Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management. , 2014, World journal of clinical oncology.